| Objective definition of rosette shape variation using a combined computer vision and data mining approach A Camargo, D Papadopoulou, Z Spyropoulou, K Vlachonasios, ... PloS one 9 (5), e96889, 2014 | 40 | 2014 |
| In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL) G Melagraki, E Ntougkos, D Papadopoulou, V Rinotas, G Leonis, E Douni, ... Frontiers in Pharmacology 9, 800, 2018 | 21 | 2018 |
| In silico identification and evaluation of natural products as potential tumor necrosis factor function inhibitors using advanced enalos asclepios KNIME nodes D Papadopoulou, A Drakopoulos, P Lagarias, G Melagraki, G Kollias, ... International journal of molecular sciences 22 (19), 10220, 2021 | 14 | 2021 |
| Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis D Papadopoulou, F Roumelioti, C Tzaferis, P Chouvardas, AK Pedersen, ... JCI insight 8 (9), 2023 | 7 | 2023 |
| Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment L Ntari, C Nikolaou, K Kranidioti, D Papadopoulou, ... Journal of translational medicine 19 (1), 165, 2021 | 6 | 2021 |
| Discovery of the First‐in‐Class Inhibitors of Hypoxia Up‐Regulated Protein 1 (HYOU1) Suppressing Pathogenic Fibroblast Activation D Papadopoulou, V Mavrikaki, F Charalampous, C Tzaferis, M Samiotaki, ... Angewandte Chemie International Edition 63 (14), e202319157, 2024 | 2 | 2024 |
| miR-221/222 drive synovial fibroblast expansion and pathogenesis of TNF-mediated arthritis F Roumelioti, C Tzaferis, D Konstantopoulos, D Papadopoulou, A Prados, ... bioRxiv, 2022.07. 22.500939, 2022 | 2 | 2022 |
| Mir221/222 drive synovial hyperplasia and arthritis by targeting cell cycle inhibitors and chromatin remodeling components F Roumelioti, C Tzaferis, D Konstantopoulos, D Papadopoulou, A Prados, ... eLife 13, e84698, 2024 | | 2024 |
| Repurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts activation in arthritis D Papadopoulou, F Roumelioti, C Tzaferis, P Chouvardas, AK Pedersen, ... bioRxiv, 2022.08. 02.500956, 2022 | | 2022 |
| Identifying new small molecule inhibitors for the therapy of chronic inflammatory diseases: developing of a novel screening pipeline D Papadopoulou Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Σχολή Επιστημών Υγείας …, 2022 | | 2022 |
| 05.17 An integrated chemoinformatics-aided pipeline for the discovery of small–molecule dual inhibitors of tnf and rankl D Papadopoulou, G Melagraki, E Ntougkos, V Rinotas, E Douni, ... Annals of the Rheumatic Diseases 76 (Suppl 1), A59-A59, 2017 | | 2017 |
